Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Characterization of hepatitis delta virus strains spreading in Abuja, Nigeria.

Ifeorah IM, Faleye TOC, Bakarey AS, Adewumi OM, Gerber A, Le Gal F, Adeniji JA, Gordien E, Onyemelukwe NF.

J Med Virol. 2019 Sep;91(9):1688-1692. doi: 10.1002/jmv.25503. Epub 2019 Jun 25.

PMID:
31081541
2.

Baroreflex sensitivity assessed with the sequence method is associated with ventricular arrhythmias in patients implanted with a defibrillator for the primary prevention of sudden cardiac death.

Garcia R, Degand B, Fraty M, Le Marcis V, Bidegain N, Laude D, Tavernier M, Le Gal F, Hadjadj S, Saulnier PJ, Ragot S.

Arch Cardiovasc Dis. 2019 Apr;112(4):270-277. doi: 10.1016/j.acvd.2018.11.009. Epub 2019 Jan 19.

PMID:
30670362
3.

Contractibility sensor signal evolution predicts cardiovascular events in patients with cardiac resynchronization therapy.

Garcia R, Guenancia C, Le Gal F, Rehman M, Tao V, Christiaens L, Ingrand P, Degand B.

Arch Cardiovasc Dis. 2019 Jan;112(1):22-30. doi: 10.1016/j.acvd.2018.07.003. Epub 2018 Dec 24.

PMID:
30591324
4.

Hepatitis B virus and hepatitis delta virus subtypes circulating in Algeria and seroprevalence of HDV infection.

Gourari S, Brichler S, Le Gal F, Abdou-Chekaraou M, Beloufa MA, Khelifa R, Djaballah H, Boufekane M, Nani A, Afredj N, Debzi N, Dény P, Gordien E, Tazir M.

J Med Virol. 2019 Jan;91(1):72-80. doi: 10.1002/jmv.25301. Epub 2018 Sep 24.

PMID:
30168584
5.

High prevalence and diversity of hepatitis B and hepatitis delta virus in Gabon.

Groc S, Abbate JL, Le Gal F, Gerber A, Tuaillon E, Albert JL, Nkoghé D, Leroy EM, Roche B, Becquart P.

J Viral Hepat. 2019 Jan;26(1):170-182. doi: 10.1111/jvh.12991. Epub 2018 Sep 19.

PMID:
30141209
6.

Twenty-four-hour ambulatory ECG monitoring relevancy in myotonic dystrophy type 1 follow-up: Prognostic value and heart rate variability evolution.

Gamet A, Degand B, Le Gal F, Bidegain N, Delaubier A, Gilbert-Dussardier B, Christiaens L, Garcia R.

Ann Noninvasive Electrocardiol. 2019 Jan;24(1):e12587. doi: 10.1111/anec.12587. Epub 2018 Aug 12.

PMID:
30101452
7.

Hepatitis B and hepatitis D virus infections in the Central African Republic, twenty-five years after a fulminant hepatitis outbreak, indicate continuing spread in asymptomatic young adults.

Komas NP, Ghosh S, Abdou-Chekaraou M, Pradat P, Al Hawajri N, Manirakiza A, Laghoe GL, Bekondi C, Brichler S, Ouavéné JO, Sépou A, Yambiyo BM, Gody JC, Fikouma V, Gerber A, Abeywickrama Samarakoon N, Alfaiate D, Scholtès C, Martel N, Le Gal F, Lo Pinto H, Amri I, Hantz O, Durantel D, Lesbordes JL, Gordien E, Merle P, Drugan T, Trépo C, Zoulim F, Cortay JC, Kay AC, Dény P.

PLoS Negl Trop Dis. 2018 Apr 26;12(4):e0006377. doi: 10.1371/journal.pntd.0006377. eCollection 2018 Apr.

8.

[Repurposing of betablockers in dermatology].

Wrobel LJ, Boehncke WH, Le Gal FA.

Rev Med Suisse. 2018 Mar 28;14(600):670-675. French.

PMID:
29589653
9.

Molecular characterization of the full-length genome sequences of HDV strains circulating in Tunisia.

Yacoubi L, Brichler S, Le Gal F, Triki H, Gordien E.

Arch Virol. 2018 Jul;163(7):1727-1731. doi: 10.1007/s00705-018-3790-1. Epub 2018 Mar 7.

PMID:
29516244
10.

Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains.

Le Gal F, Brichler S, Drugan T, Alloui C, Roulot D, Pawlotsky JM, Dény P, Gordien E.

Hepatology. 2017 Dec;66(6):1826-1841. doi: 10.1002/hep.29574. Epub 2017 Oct 30.

PMID:
28992360
11.

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.

Bazinet M, Pântea V, Cebotarescu V, Cojuhari L, Jimbei P, Albrecht J, Schmid P, Le Gal F, Gordien E, Krawczyk A, Mijočević H, Karimzadeh H, Roggendorf M, Vaillant A.

Lancet Gastroenterol Hepatol. 2017 Dec;2(12):877-889. doi: 10.1016/S2468-1253(17)30288-1. Epub 2017 Sep 28. Erratum in: Lancet Gastroenterol Hepatol. 2018 Jan;3(1):e1.

PMID:
28964701
12.

Left ventricular longitudinal strain impairment predicts cardiovascular events in asymptomatic type 1 myotonic dystrophy.

Garcia R, Rehman M, Goujeau C, Degand B, Le Gal F, Stordeur B, Labarre Q, Christiaens L, Bouleti C.

Int J Cardiol. 2017 Sep 15;243:424-430. doi: 10.1016/j.ijcard.2017.05.061. Epub 2017 May 19.

PMID:
28550978
13.

High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo.

Makiala-Mandanda S, Le Gal F, Ngwaka-Matsung N, Ahuka-Mundeke S, Onanga R, Bivigou-Mboumba B, Pukuta-Simbu E, Gerber A, Abbate JL, Mwamba D, Berthet N, Leroy EM, Muyembe-Tamfum JJ, Becquart P.

J Clin Microbiol. 2017 May;55(5):1299-1312. doi: 10.1128/JCM.01847-16. Epub 2017 Feb 15.

14.

Apical left ventricular myocardial dysfunction is an early feature of cardiac involvement in myotonic dystrophy type 1.

Garcia R, Labarre Q, Degand B, Ingrand P, Le Gal F, Bonnet B, Delaubier A, Guillou C, Gellen B, Coisne D, Bouleti C, Christiaens L.

Echocardiography. 2017 Feb;34(2):184-190. doi: 10.1111/echo.13426. Epub 2017 Feb 13.

PMID:
28191665
15.

Performance Characteristics of a New Consensus Commercial Kit for Hepatitis D Virus RNA Viral Load Quantification.

Le Gal F, Dziri S, Gerber A, Alloui C, Ben Abdesselam Z, Roulot D, Brichler S, Gordien E.

J Clin Microbiol. 2017 Feb;55(2):431-441. doi: 10.1128/JCM.02027-16. Epub 2016 Nov 23.

16.

Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma.

Jean Wrobel L, Bod L, Lengagne R, Kato M, Prévost-Blondel A, Le Gal FA.

Oncotarget. 2016 Nov 22;7(47):77825-77837. doi: 10.18632/oncotarget.12833.

17.

First international external quality assessment for hepatitis delta virus RNA quantification in plasma.

Le Gal F, Brichler S, Sahli R, Chevret S, Gordien E.

Hepatology. 2016 Nov;64(5):1483-1494. doi: 10.1002/hep.28772. Epub 2016 Sep 27.

PMID:
27530084
18.

Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania.

Winter A, Letang E, Vedastus Kalinjuma A, Kimera N, Ntamatungiro A, Glass T, Moradpour D, Sahli R, Le Gal F, Furrer H, Wandeler G; KIULARCO Study Group.

Int J Infect Dis. 2016 May;46:8-10. doi: 10.1016/j.ijid.2016.03.011. Epub 2016 Mar 17.

19.

Long-term Follow-up of Longitudinal Melanonychia in Children and Adolescents Using an Objective Discrimination Index.

Koga H, Yoshikawa S, Shinohara T, Le Gal FA, Cortés B, Saida T, Sota T.

Acta Derm Venereol. 2016 Jun 15;96(5):716-7. doi: 10.2340/00015555-2349. No abstract available.

20.

Molecular epidemiology of hepatitis B and Delta virus strains that spread in the Mediterranean North East Coast of Tunisia.

Yacoubi L, Brichler S, Mansour W, Le Gal F, Hammami W, Sadraoui A, Ben Mami N, Msaddek A, Cheikh I, Triki H, Gordien E.

J Clin Virol. 2015 Nov;72:126-32. doi: 10.1016/j.jcv.2015.10.002. Epub 2015 Oct 8.

PMID:
26513762
21.

Inhibition of human melanoma growth by a non-cardioselective β-blocker.

Wrobel LJ, Le Gal FA.

J Invest Dermatol. 2015 Feb;135(2):525-531. doi: 10.1038/jid.2014.373. Epub 2014 Sep 1.

22.

A lock-in thermal imaging setup for dermatological applications.

Bonmarin M, Le Gal FA.

Skin Res Technol. 2015 Aug;21(3):284-90. doi: 10.1111/srt.12189. Epub 2014 Aug 4.

PMID:
25087689
23.

Markers of hepatitis delta virus infection can be detected in follicular fluid and semen.

Mansour W, Lemoine M, Neri Pinto F, Llabador de Royer MA, Le Gal F, Yazbeck C, Patrat C, Gordien E.

J Clin Virol. 2014 Oct;61(2):279-81. doi: 10.1016/j.jcv.2014.06.029. Epub 2014 Jul 6.

PMID:
25052331
24.

When is a child with status epilepticus likely to have Dravet syndrome?

Le Gal F, Lebon S, Ramelli GP, Datta AN, Mercati D, Maier O, Combescure C, Rodriguez MI, Seeck M, Roulet E, Korff CM.

Epilepsy Res. 2014 May;108(4):740-7. doi: 10.1016/j.eplepsyres.2014.02.019. Epub 2014 Mar 12.

PMID:
24679980
25.

Lock-in thermal imaging for the early-stage detection of cutaneous melanoma: a feasibility study.

Bonmarin M, Le Gal FA.

Comput Biol Med. 2014 Apr;47:36-43. doi: 10.1016/j.compbiomed.2014.01.008. Epub 2014 Jan 25.

PMID:
24530537
26.

Serological and molecular diagnosis of hepatitis delta virus infection: results of a French national quality control study.

Brichler S, Le Gal F, Neri-Pinto F, Mansour W, Roulot D, Laperche S, Gordien E.

J Clin Microbiol. 2014 May;52(5):1694-7. doi: 10.1128/JCM.03521-13. Epub 2014 Feb 12.

27.

Increasing prevalence of HDV/HBV infection over 15 years in France.

Servant-Delmas A, Le Gal F, Gallian P, Gordien E, Laperche S.

J Clin Virol. 2014 Feb;59(2):126-8. doi: 10.1016/j.jcv.2013.11.016. Epub 2013 Dec 7.

PMID:
24365475
28.

Pruritic acquired nevus of Ota.

Quenan S, Strueven V, Saxer N, Laffitte E, Kaya G, Krischer J, Hafezi F, Le Gal FA.

Dermatology. 2013;227(2):186-8. doi: 10.1159/000354604. Epub 2013 Sep 20.

PMID:
24060704
29.

African, Amerindian and European hepatitis B virus strains circulate on the Caribbean Island of Martinique.

Brichler S, Lagathu G, Chekaraou MA, Le Gal F, Edouard A, Dény P, Césaire R, Gordien E.

J Gen Virol. 2013 Oct;94(Pt 10):2318-29. doi: 10.1099/vir.0.055459-0. Epub 2013 Jul 24.

PMID:
23884366
30.

Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.

Lunel-Fabiani F, Mansour W, Amar AO, Aye M, Le Gal F, Malick FZ, Baïdy L, Brichler S, Veillon P, Ducancelle A, Gordien E, Rosenheim M.

J Infect. 2013 Nov;67(5):448-57. doi: 10.1016/j.jinf.2013.06.008. Epub 2013 Jun 22.

PMID:
23796871
31.

Real-time PCR for quantitative analysis of human commensal Escherichia coli populations reveals a high frequency of subdominant phylogroups.

Smati M, Clermont O, Le Gal F, Schichmanoff O, Jauréguy F, Eddi A, Denamur E, Picard B; Coliville Group.

Appl Environ Microbiol. 2013 Aug;79(16):5005-12. doi: 10.1128/AEM.01423-13. Epub 2013 Jun 14.

32.

Commercial real-time reverse transcriptase PCR assays can underestimate or fail to quantify hepatitis delta virus viremia.

Brichler S, Le Gal F, Butt A, Chevret S, Gordien E.

Clin Gastroenterol Hepatol. 2013 Jun;11(6):734-40. doi: 10.1016/j.cgh.2013.01.025. Epub 2013 Feb 1.

PMID:
23376798
33.

Dermoscopy of desmoplastic trichoepithelioma reveals other criteria to distinguish it from basal cell carcinoma.

Khelifa E, Masouyé I, Kaya G, Le Gal FA.

Dermatology. 2013;226(2):101-4. doi: 10.1159/000346246. Epub 2013 Jan 30.

PMID:
23363889
34.

Prevalence, risk factors, and molecular epidemiology of hepatitis B and hepatitis delta virus in pregnant women and in patients in Mauritania.

Mansour W, Malick FZ, Sidiya A, Ishagh E, Chekaraou MA, Veillon P, Ducancelle A, Brichler S, Le Gal F, Lo B, Gordien E, Lunel-Fabiani F.

J Med Virol. 2012 Aug;84(8):1186-98. doi: 10.1002/jmv.23336.

PMID:
22711346
35.

Virological and epidemiological features of hepatitis delta infection among blood donors in Nouakchott, Mauritania.

Mansour W, Bollahi MA, Hamed CT, Brichler S, Le Gal F, Ducancelle A, Lô B, Gordien E, Rosenheim M, Lunel F.

J Clin Virol. 2012 Sep;55(1):12-6. doi: 10.1016/j.jcv.2012.05.011. Epub 2012 Jun 14.

PMID:
22704272
36.

[I have a brown/pigmented spot on my skin].

Le Gal FA.

Rev Med Suisse. 2012 Feb 22;8(329):430-3. French. No abstract available.

PMID:
22432245
37.

Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins.

Le Gal F, Badur S, Hawajri NA, Akyüz F, Kaymakoglu S, Brichler S, Zoulim F, Gordien E, Gault E, Dény P.

Arch Virol. 2012 Apr;157(4):647-59. doi: 10.1007/s00705-011-1212-8. Epub 2012 Jan 13.

PMID:
22241621
38.

Antiestrogen therapy for breast cancer modifies the risk of subsequent cutaneous melanoma.

Huber C, Bouchardy C, Schaffar R, Neyroud-Caspar I, Vlastos G, Le Gal FA, Rapiti E, Benhamou S.

Cancer Prev Res (Phila). 2012 Jan;5(1):82-8. doi: 10.1158/1940-6207.CAPR-11-0332. Epub 2011 Sep 20.

39.

Replication of association between a SCN1A splice variant and febrile seizures.

Le Gal F, Salzmann A, Crespel A, Malafosse A.

Epilepsia. 2011 Oct;52(10):e135-8. doi: 10.1111/j.1528-1167.2011.03164.x. Epub 2011 Jul 18.

40.

[Lentigo maligna: a special melanoma].

Le Gal FA, Toutous-Trellu L, Kaya G, Salomon D.

Rev Med Suisse. 2011 Apr 6;7(289):765-6, 768-71. French.

PMID:
21568099
41.

A case of SUDEP in a patient with Dravet syndrome with SCN1A mutation.

Le Gal F, Korff CM, Monso-Hinard C, Mund MT, Morris M, Malafosse A, Schmitt-Mechelke T.

Epilepsia. 2010 Sep;51(9):1915-8. doi: 10.1111/j.1528-1167.2010.02691.x.

42.

[Pigmented lesions of the trunk].

Khelifa E, Pham HC, Le Gal FA.

Ann Dermatol Venereol. 2010 May;137(5):418-9. doi: 10.1016/j.annder.2010.03.005. Epub 2010 Apr 14. French. No abstract available.

PMID:
20470928
43.

A novel hepatitis B virus (HBV) subgenotype D (D8) strain, resulting from recombination between genotypes D and E, is circulating in Niger along with HBV/E strains.

Abdou Chekaraou M, Brichler S, Mansour W, Le Gal F, Garba A, Dény P, Gordien E.

J Gen Virol. 2010 Jun;91(Pt 6):1609-20. doi: 10.1099/vir.0.018127-0. Epub 2010 Feb 10.

PMID:
20147517
44.

Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine.

Mansour W, Ducancelle A, Le Gal F, Le Guillou-Guillemette H, Abgueguen P, Pivert A, Calès P, Gordien E, Lunel F.

J Clin Virol. 2010 Jan;47(1):97-9. doi: 10.1016/j.jcv.2009.09.027. Epub 2009 Nov 13.

PMID:
19914127
45.

Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvant.

Lienard D, Avril MF, Le Gal FA, Baumgaertner P, Vermeulen W, Blom A, Geldhof C, Rimoldi D, Pagliusi S, Romero P, Dietrich PY, Corvaia N, Speiser DE.

J Immunother. 2009 Oct;32(8):875-83. doi: 10.1097/CJI.0b013e3181b56ad9.

PMID:
19752746
46.

[Scleroedema adultorum Buschke in a diabetic subject: intravenous immunoglobulin therapy].

Barde C, Masouyé I, Saurat JH, Le Gal FA.

Ann Dermatol Venereol. 2009 Apr;136(4):360-3. doi: 10.1016/j.annder.2008.09.024. Epub 2009 Feb 26. French.

PMID:
19361705
47.

Genetic and epigenetic analysis of SSAT gene dysregulation in suicidal behavior.

Guipponi M, Deutsch S, Kohler K, Perroud N, Le Gal F, Vessaz M, Laforge T, Petit B, Jollant F, Guillaume S, Baud P, Courtet P, La Harpe R, Malafosse A.

Am J Med Genet B Neuropsychiatr Genet. 2009 Sep 5;150B(6):799-807. doi: 10.1002/ajmg.b.30901.

PMID:
19051286
48.

Management of subacute and delayed right ventricular perforation with a pacing or an implantable cardioverter-defibrillator lead.

Laborderie J, Barandon L, Ploux S, Deplagne A, Mokrani B, Reuter S, Le Gal F, Jais P, Haissaguerre M, Clementy J, Bordachar P.

Am J Cardiol. 2008 Nov 15;102(10):1352-5. doi: 10.1016/j.amjcard.2008.07.025. Epub 2008 Sep 12.

PMID:
18993154
49.

Chemokine analogues show suitable stability for development as microbicides.

Cerini F, Landay A, Gichinga C, Lederman MM, Flyckt R, Starks D, Offord RE, Le Gal F, Hartley O.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):472-6. doi: 10.1097/QAI.0b013e31818c953f.

PMID:
18989226
50.

Variability of gB and gH genes of human herpesvirus-6 among clinical specimens.

Achour A, Malet I, Le Gal F, Dehée A, Gautheret-Dejean A, Bonnafous P, Agut H.

J Med Virol. 2008 Jul;80(7):1211-21. doi: 10.1002/jmv.21205.

PMID:
18461623

Supplemental Content

Loading ...
Support Center